Last edition
News about "Actis Generics"
RPG Life Sciences Subsidiary to Acquire Raghava Life Sciences' API Business for Up to INR 135 Crore
RPG Active Pharma’s latest acquisition expands its manufacturing capacity, API portfolio and regulatory capabilities as part of its buy-and-build strategy.
Actis Generics | 03/09/2026 | By Akanki
RPG Life Sciences Launches Strategic API Growth Initiative
RPG Life Sciences has launched a strategic Active Pharmaceutical Ingredient (API) initiative, with InvAscent investing in RPG Active Pharma and the unit acquiring Actis Generics.
Actis Generics | 31/07/2026 | By News Bureau | 650
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy